The FDA has approved Xuriden (uridine triacetate), from Wellstat Therapeutics, the first FDA-approved treatment for patients with hereditary orotic aciduria....
Wellstat Therapeutics’ new drug application (NDA) for Xuriden (uridine triacetate) has been accepted for review by the FDA as an...